These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9632352)

  • 1. A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.
    Jacobson KA; Kim YC; Wildman SS; Mohanram A; Harden TK; Boyer JL; King BF; Burnstock G
    J Med Chem; 1998 Jun; 41(13):2201-6. PubMed ID: 9632352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.
    Kim YC; Brown SG; Harden TK; Boyer JL; Dubyak G; King BF; Burnstock G; Jacobson KA
    J Med Chem; 2001 Feb; 44(3):340-9. PubMed ID: 11462975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cultured dorsal root ganglion neuron P2X receptors.
    Grubb BD; Evans RJ
    Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, tissue distribution and functional characterization of the chicken P2X1 receptor.
    Soto F; Krause U; Borchardt K; Ruppelt A
    FEBS Lett; 2003 Jan; 533(1-3):54-8. PubMed ID: 12505158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.
    Lewis CJ; Evans RJ
    Br J Pharmacol; 2000 Dec; 131(8):1659-66. PubMed ID: 11139444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
    Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation and desensitization of the recombinant P2X1 receptor at nanomolar ATP concentrations.
    Rettinger J; Schmalzing G
    J Gen Physiol; 2003 May; 121(5):451-61. PubMed ID: 12719485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2x-purinoceptors of myenteric neurones from the guinea-pig ileum and their unusual pharmacological properties.
    Barajas-López C; Huizinga JD; Collins SM; Gerzanich V; Espinosa-Luna R; Peres AL
    Br J Pharmacol; 1996 Dec; 119(8):1541-8. PubMed ID: 8982499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages.
    Bowler JW; Bailey RJ; North RA; Surprenant A
    Br J Pharmacol; 2003 Oct; 140(3):567-75. PubMed ID: 12970084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels.
    Nicke A; Bäumert HG; Rettinger J; Eichele A; Lambrecht G; Mutschler E; Schmalzing G
    EMBO J; 1998 Jun; 17(11):3016-28. PubMed ID: 9606184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mechanism of inhibition by the P2 receptor antagonist PPADS of ATP-activated current in dorsal root ganglion neurons.
    Li C
    J Neurophysiol; 2000 May; 83(5):2533-41. PubMed ID: 10805655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic and vanilloid receptor activation releases glutamate from separate cranial afferent terminals in nucleus tractus solitarius.
    Jin YH; Bailey TW; Li BY; Schild JH; Andresen MC
    J Neurosci; 2004 May; 24(20):4709-17. PubMed ID: 15152030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus.
    Rodrigues RJ; Almeida T; Richardson PJ; Oliveira CR; Cunha RA
    J Neurosci; 2005 Jul; 25(27):6286-95. PubMed ID: 16000618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of the P2X(4) receptor orthologues.
    Jones CA; Chessell IP; Simon J; Barnard EA; Miller KJ; Michel AD; Humphrey PP
    Br J Pharmacol; 2000 Jan; 129(2):388-94. PubMed ID: 10694247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
    De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
    Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor.
    Kim YC; Lee JS; Sak K; Marteau F; Mamedova L; Boeynaems JM; Jacobson KA
    Biochem Pharmacol; 2005 Jul; 70(2):266-74. PubMed ID: 15913566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective potentiation of homomeric P2X2 ionotropic ATP receptors by a fast non-genomic action of progesterone.
    De Roo M; Boué-Grabot E; Schlichter R
    Neuropharmacology; 2010 Mar; 58(3):569-77. PubMed ID: 20004677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation.
    Resende RR; Majumder P; Gomes KN; Britto LR; Ulrich H
    Neuroscience; 2007 May; 146(3):1169-81. PubMed ID: 17418494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.
    Nandanan E; Camaioni E; Jang SY; Kim YC; Cristalli G; Herdewijn P; Secrist JA; Tiwari KN; Mohanram A; Harden TK; Boyer JL; Jacobson KA
    J Med Chem; 1999 May; 42(9):1625-38. PubMed ID: 10229631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The purinergic component of human vas deferens contraction.
    Banks FC; Knight GE; Calvert RC; Thompson CS; Morgan RJ; Burnstock G
    Fertil Steril; 2006 Apr; 85(4):932-9. PubMed ID: 16580377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.